Andrius Dambrauskas

Experience

• 

  Schering-Plough

  Jan 2008 - Jan 2009

  Senior Product Specialist Hepatitis C
• 

  Merck Sharp & Dohme

  Jan 2009 - Jan 2012

  Sales Manager Primary Care

  Allergology & Dermatology products | OTCBusiness development, environment and business results analysis.Budgeting and forecasting demand, revenues and expenses.Sales targets achievement.Develope and maintain relationships with Key Opinion Leaders, wholesalersand pharmacy chains.Coaching sales team of medical representatives.Lead Sales Meetings, provide trainings.Co-visiting.Coordinate marketing strategy implementation, provide colleagues informationfrom "fields" about marketing strategy effectiveness, competitors, medicalenviroment situation.Territory segmentation.Motivation and creation of healthy enviroment to work. Show less

• 

  Merck

  Jan 2013 - Jan 2014

  Therapeutic Areas: Hepatitis C, Antibiotics, Antifungals, Oncology, HIV products Business development initiatives to expand market presence and drive revenue growth. Developed and managed budgets, demand forecasts, and financial projections for revenue and expenses. Consistently achieved sales targets through strategic planning and execution. Designed and implemented comprehensive marketing plans tailored to product portfolios. Organized and executed seminars, expert meetings, exhibitions, and participation in international congresses. Conducted in-depth market research, filed new products for reimbursement, and prepared and submitted product dossiers for centralized purchasing. Managed key customer relationships by building and maintaining strong connections with key opinion leaders, decision-makers, and governmental officials. Led sales meetings, provided training, and developed a high-performing sales team of Key Account Specialists.Key Accomplishments: PEGINTRON (Hepatitis C): Secured support and advocacy from leading scientific experts. Played a pivotal role in the preparation of national Hepatitis C treatment guidelines favoring Pegintron, resulting in Ministry of Health approval. Maintained and slightly increased market leadership (YTD Oct 2012, units, Rx data). CANCIDAS (Antifungal): Increased annual Sick Fund tender allocation for Cancidas by 15%. Facilitated the preparation of antifungal treatment guidelines favoring Cancidas within the LSMUL Hematology and Transplantation departments. Show less

  • Business Unit Manager, Hospital Portfolio

    Jan 2013 - Jan 2014

  • Key Account Manager, Hepatitis C & HIV

    Jan 2013 - Jan 2013
• 

  Bionorica

  Feb 2014 - Apr 2024

  Leading Bionorica business in the BalticsDevelop and execute strategic initiatives.Oversee P&L management to drive business growth.Lead strategic negotiations with key business partners to achieve mutually beneficial outcomes.Manage HR functions, including recruitment, employee development, promotions, and retirement.Inspire and guide teams to achieve organizational success.Collaborate with the executive board to define company values, set the mission, and plan short- and long-term goals.Ensure the accurate filing of legal and regulatory documents while complying with all applicable laws and regulations.Accomplishments:Built and unified a high-performing team of professionals, consistently achieving ambitious goals.Elevated the Sinupret brand to rank as the No. 2 OTC product by value in Lithuania and Latvia in 2022. Show less

  • Country Manager Baltics

    Mar 2017 - Apr 2024

  • Marketing Manager

    Feb 2015 - Mar 2017

  • Sales Manager for Baltic Countries

    Feb 2014 - Feb 2015
• 

  Dfarma

  Jan 2024 - now

  Founder

  Pharmaceutical consultancy servicesBusiness Development Projects

• 

  Ambercell Solutions

  Jan 2025 - now

  Head of Pharma Management Solutions Baltic

  The Closed-Loop Medication Management Solutions for Safer workflows in HealthCareStrategy & Implementation.